ライフサイエンスコーパス: GABA(A) receptor agonist

1 unit gamma2 (TAT-GABAgamma2) and muscimol, a GABAA receptor agonist.

2 by reducing levels of methylglyoxal (MG), a GABAA receptor agonist.

3 ying 2 mum glycine or 0.1 mum isoguvacine, a GABAA-receptor agonist.

4 ecting brain-state switching when exposed to GABAA-receptor agonists.

5 was prevented by coinjection to the VMH of a GABA(A) receptor agonist.

6 ical properties of natural ALLO but is not a GABA(A) receptor agonist.

7 r phenotype in C57BL/6J mice by infusing the GABAA receptor agonist, 4,5,6,7-tetrahydroisoxazolo-[5,4

8 In addition, GABA(A) receptor agonists activated a tonic current in R

9 s can be suppressed by microinjection of the GABA(A) receptor agonist and neuronal inhibitor muscimol

10 to compare binding and unbinding kinetics of GABA(A) receptor agonists and antagonists in outside-out

11 Muscimol, a GABA(A) receptor agonist at a dose of 5 ng, injected int

12 o target recordings from SACs, we found that GABA(A) receptor agonists blocked compound postsynaptic

13 Lorazepam, a GABA(A) receptor agonist, blocked this increased excitab

14 or antagonist, bicuculline (3-30 ng), or the GABA(A) receptor agonists, chlordiazepoxide, a benzodiaz

15 -3-ol, gaboxadol], a delta-subunit-selective GABA(A) receptor agonist, decreases seizure-like activit

16 Neither GABA(A) receptor agonist elevated aggression, which coul

17 ats by locally concentrating and releasing a GABA(A) receptor agonist from ultrasound-controlled carr

18 A GABAA receptor agonist, Glu receptor antagonists, or a G

19 oxypyrazole (4-AHP) analogues of muscimol, a GABA(A) receptor agonist, has been synthesized and pharm

20 glutamate receptor antagonist) and muscimol (GABAA receptor agonist) in the SubC virtually eliminated

21 efficacy of dendrite-targeting, low-potency GABA(A) receptor agonists, independent of sex and despit

22 orms in lethargus show partial resistance to GABA(A) receptor agonists, indicating that postsynaptic

23 Herein, we report that "moxidectin," a GABA(A) receptor agonist, inhibits the proliferation of

24 n rats by microinjection of small amounts of GABAA-receptor agonists into an upper brainstem region n

25 ion was disrupted by infusion of muscimol, a GABA(A) receptor agonist, into the DH.

26 In experiment 1, infusion of muscimol, a GABAA receptor agonist, into the dorsal hippocampus befo

27 Pretraining infusions of muscimol, a GABAA receptor agonist, into the VH disrupted auditory,

28 ynaptic responsiveness to local puffs of the GABAA receptor agonist isoguvacine.

29 id and 6-cyano-7-nitro-quinoxalone) and by a GABAA receptor agonist (isoguvacine) when these agents w

30 Control experiments using a GABAA receptor agonist, isoguvacine, indicated that both

31 The GABA(A) receptor-agonist lorazepam increased the amplitu

32 ted with artificial extracellular fluid, the GABA(A) receptor agonist muscimol (1 nmol/side), or the

33 assessed before, and after, injection of the GABA(A) receptor agonist muscimol 80 pmol (100 nl)(-1) o

34 Bath application of the GABA(A) receptor agonist muscimol blocked spontaneous co

35 In intact cells, GABA and the GABA(A) receptor agonist muscimol caused a rapid and tra

36 ansition, but not the Vc/C1 junction, by the GABA(A) receptor agonist muscimol inhibited CO2-evoked t

37 The GABA(A) receptor agonist muscimol inhibited learning in

38 ient inactivation of OFC by infusions of the GABA(A) receptor agonist muscimol into area 13 blocked t

39 ects on the hippocampus by microinfusing the GABA(A) receptor agonist muscimol into the amygdala and

40 orary inactivation of the amygdala using the GABA(A) receptor agonist muscimol just before the onset

41 profound effects of the exogenously applied GABA(A) receptor agonist muscimol or glycine, either of

42 Furthermore, the GABA(A) receptor agonist muscimol produced a dose-depend

43 ng blockade of the contralateral BotC by the GABA(A) receptor agonist muscimol significantly reduced

44 lamic nucleus (DMH) by microinjection of the GABA(A) receptor agonist muscimol suppresses cardiovascu

45 nto the PnO of saline (vehicle control), the GABA(A) receptor agonist muscimol, muscimol with the GAB

46 closer glybenclamide, 4) diazoxide plus the GABA(A) receptor agonist muscimol, or 5) glybenclamide p

47 ion of the medial prefrontal cortex with the GABA(A) receptor agonist muscimol, which eliminates the

48 Inhibition of RTN neurons with the GABA(A) receptor agonist muscimol, with simultaneous dia

49 Bath application of GABA(A) receptor agonists muscimol (250 microM) or pento

50 n affibody plus a gamma-aminobutyric acid A (GABA(A)) receptor agonist muscimol, prior to a hypoglyce

51 Effects of spinal administration of the GABA(A)-receptor agonist muscimol (0.1-30 microg/50 micr

52 Injection of the GABA(A)-receptor agonist muscimol, but not naloxone, int

53 we characterized the in vitro effects of the GABAA receptor agonist muscimol (0.5, 0.25, 0.1 and 0.06

54 in explants cultured in the presence of the GABAA receptor agonist muscimol (10(-4) M).

55 TS) with glycine (40 nmol/80 nl) or with the GABAA receptor agonist muscimol (160 pmol/80 nl; 77 +/-

56 The GABAA receptor agonist muscimol also induced oxytocin re

57 ns into specific parietal circuits using the GABAA receptor agonist muscimol and validated the lesion

58 e same region by local microinjection of the GABAA receptor agonist muscimol can virtually abolish st

59 ivity in RA by intracerebral infusion of the GABAA receptor agonist muscimol decreased the number of

60 Whereas the GABAA receptor agonist muscimol evoked excitatory, inhib

61 Bilateral microinjection of the GABAA receptor agonist muscimol into the caudal ventrola

62 gm, we examined the effects of injecting the GABAA receptor agonist muscimol or the GABAA receptor an

63 cells in the AcbSh via administration of the GABAA receptor agonist muscimol or the GABAB receptor ag

64 a-aminobutyric acid (GABA), the GABA type a (GABAa) receptor agonist muscimol, and the GABAa receptor

65 Unilateral microinjection of a GABA(A) receptor agonist (muscimol, 200 pmol) into STN p

66 xperiment 1 examined whether infusion of the GABA(A) receptor agonist, muscimol (0.0, 4.4, 8.8 nmol),

67 (RVLM) with bilateral microinjections of the GABA(A) receptor agonist, muscimol (6 mM, 50 nl) which m

68 nown to modulate the specific binding of the GABA(A) receptor agonist, muscimol, in certain brain reg

69 g 0.2 microl of 1 mM or 10 mM solutions of a GABA(A) receptor agonist, muscimol, into the MnPN on Fos

70 The GABAA receptor agonist, muscimol (0.3-30 pmol), microinj

71 Conversely, microinfusions of the GABAA receptor agonist, muscimol (10, 25 and 50 pmol), i

72 Our results also demonstrated that the GABAA receptor agonist, muscimol, enhances pulsatile GnR

73 Either isoguvacine (a GABA(A) receptor agonist) or kynurenic acid (a non-selec

74 ed ataxia when administered the nonselective GABA(A) receptor agonists pentobarbital and pregnanolone

75 1 enzyme, which metabolizes methylglyoxal-a GABA(A) receptor agonist produced by glycolysis.

76 e studied the influence of lorazepam (LZ) (a GABA(A) receptor agonist) relative to that of dextrometh

77 At 4 degrees C, muscimol, a GABAA receptor agonist, stimulated 36Cl- efflux with an

78 GABA(A) receptor agonists such as Ativan are a widely pr

79 ief applications of the weakly desensitizing GABA(A) receptor agonists taurine and beta-alanine.

80 ute treatment with a peripherally restricted GABA(A) receptor agonist that acts directly on mechanose

81 THIP, a GABA(A) receptor agonist that preferentially activates d

82 tors declines in cortical neurons exposed to GABAA receptor agonists, the mechanisms responsible for

83 Application of the delta subunit GABAA receptor agonist THIP resulted in a tonic GABAA re

84 ist bicuculline or a selective extrasynaptic GABAA receptor agonist THIP, were significantly reduced

85 Administration of muscimol (GABA(A) receptor agonist) to the APC immediately suppres

86 er an intra-amygdala infusion of muscimol, a GABA(A) receptor agonist, to inactivate BLA neurons or a

87 ed to characterize the effect of muscimol, a GABAA receptor agonist, to enhance pulsatile gonadotropi

88 ergic 5-HT(3), or gamma-aminobutyric acid A (GABA(A)) receptor agonists were unaffected by brilliant